Healthcare
Innovative Midfoot Solutions
August 27, 2026
More than 11 million Americans over the age of 50 are affected by debilitating midfoot osteoarthritis, now there’s a solution
More than 11 million Americans over the age of 50 are affected by debilitating midfoot osteoarthritis, now there’s a solution
PortIO is the first intraosseous port that provides long-term vascular access, maintenance-free operation, fewer infections, and broad clinical applicability
Leaders from science, public policy, and patient advocacy improving the lives of people living with depression and other mental health conditions
troCarWash has the potential to shorten operation times, improve outcomes, and reduce costs
Trethera targets an enzyme that is highly active across many solid tumors, autoimmune diseases, and inflammatory disorders
Warp Speed has created an operating ecosystem that enables acquired businesses to grow faster and scale larger than they could on their own
Warp Speed has created an operating ecosystem that enables acquired businesses to grow faster and scale larger than they could on their own
MadSci is developing the world’s first SmartShunt, that uses an intercranial fluid sensor to monitor and control a ICF pressure
Object Pharma is creating a novel, non-systemic neurotoxin platform to help solve today’s mental health crisis
Object Pharma is creating a novel, non-systemic neurotoxin platform to help solve today’s mental health crisis
MadSci is developing the world’s first SmartShunt, that uses an intercranial fluid sensor to monitor and control a ICF pressure
Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.